Effects of losartan treatment on the physicochemical properties of diabetic rat bone.

Donmez BO, Unal M, Ozdemir S, Ozturk N, Oguz N, Akkus O
J Bone Miner Metab. 2017 35 (2): 161-170

PMID: 27038987 · DOI:10.1007/s00774-016-0748-9

Inhibitors of the renin-angiotensin system used to treat several diseases have also been shown to be effective on bone tissue, suggesting that angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may reduce fracture risk. The present study investigated the effects of losartan on the physicochemical and biomechanical properties of diabetic rat bone. Losartan (5 mg/kg/day) was administered via oral gavage for 12 weeks. Bone mineral density (BMD) was measured using dual-energy X-ray absorptiometry. Whole femurs were tested under tension to evaluate the biomechanical properties of bone. The physicochemical properties of bone were analyzed by Fourier transform infrared spectroscopy. Although losartan did not recover decreases in the BMD of diabetic bone, it recovered the physicochemical (mineral and collagen matrix) properties of diabetic rat bone. Furthermore, losartan also recovered ultimate tensile strength of diabetic rat femurs. Losartan, an angiotensin II type 1 receptor blocker, has a therapeutic effect on the physicochemical properties of diabetic bone resulting in improvement of bone strength at the material level. Therefore, specific inhibition of this pathway at the receptor level shows potential as a therapeutic target for diabetic patients suffering from bone diseases such as osteopenia.

MeSH Terms (13)

Absorptiometry, Photon Angiotensin II Type 1 Receptor Blockers Animals Biomechanical Phenomena Bone and Bones Bone Density Diabetes Mellitus, Experimental Female Losartan Rats Rats, Wistar Renin-Angiotensin System Spectroscopy, Fourier Transform Infrared

Connections (1)

This publication is referenced by other Labnodes entities: